CivaTech Oncology and NYU Langone Health Launch NIH-sponsored Trial to Fight Lung Cancer
October 27, 2020 08:34 AM Eastern Daylight Time
RTP firm CivaTech receives FDA approval for third radiation therapy device
by Jim Shamp, NCBiotech Writer — October 1, 2019
CivaTech Oncology, a Research Triangle Park company developing a unique platform of cancer therapy devices, has received marketing approval from the U.S. Food and Drug Administration for its new CivaDerm skin cancer treatment device.